Evidence map›Paper›PMID 37378647›Full record

ArticleAdvanced healthcare materials2023

Doxorubicin-Loaded Microrobots for Targeted Drug Delivery and Anticancer Therapy.

Sudipta Mallick, Ramadan Abouomar, David Rivas, Max Sokolich, Fatma Ceren Kirmizitas, Aditya Dutta, Sambeeta Das

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Peanut Shaped Microrobots for Anticancer Therapy.... International Conference on Manipulation Automation and Robotics at Small Scales (MARSS). International Conference on Manipulation Automation and Robotics at Small Scales · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Targeted Vibration-Induced Necrosis in Liver Cancer Cells using Paramagnetic Microrobots.... International Conference on Manipulation Automation and Robotics at Small Scales (MARSS). International Conference on Manipulation Automation and Robotics at Small Scales · 2023
    Article
  11. Programmable Modular Acoustic Microrobots.... International Conference on Manipulation Automation and Robotics at Small Scales (MARSS). International Conference on Manipulation Automation and Robotics at Small Scales · 2023
    Article
  12. Rolling Helical Microrobots for Cell Patterning.... International Conference on Manipulation Automation and Robotics at Small Scales (MARSS). International Conference on Manipulation Automation and Robotics at Small Scales · 2023
    Article
  13. Closed Loop Control of Bubble-Propelled Microrobots.... International Conference on Manipulation Automation and Robotics at Small Scales (MARSS). International Conference on Manipulation Automation and Robotics at Small Scales · 2023
    Article
  14. Magnetic Microrobots as a Platform for Cell Clean Up.... International Conference on Manipulation Automation and Robotics at Small Scales (MARSS). International Conference on Manipulation Automation and Robotics at Small Scales · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sudipta MallickDepartment of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA.ORCID 0000-0001-7587-1714
Ramadan AbouomarDepartment of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA.
David RivasDepartment of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA.
Max SokolichDepartment of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA.
Fatma Ceren KirmizitasDepartment of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA.
Aditya DuttaDepartment of Animal and Food Sciences, University of Delaware, Newark, DE, 19716, USA.
Sambeeta DasDepartment of Mechanical Engineering, University of Delaware, Newark, DE, 19716, USA.ORCID 0000-0002-0605-4021

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI MELINDA K DUNCAN · 2012 to 2026
$67.2M
Controlling Cellular Fate using MicromachinesR35GM147451 · NIGMS · UNIVERSITY OF DELAWARE · PI Sambeeta Das · 2022 to 2026
$2.0M
NIGMS NIH HHS P20 GM103446NIGMS NIH HHS R35 GM147451
6 · The paper itself

Abstract

Micro-sized magnetic particles (also known as microrobots [MRs]) have recently been shown to have potential applications for numerous biomedical applications like drug delivery, microengineering, and single cell manipulation. Interdisciplinary studies have demonstrated the ability of these tiny particles to actuate under the action of a controlled magnetic field that not only drive MRs in a desired trajectory but also precisely deliver therapeutic payload to the target site. Additionally, optimal concentrations of therapeutic molecules can also be delivered to the desired site which is cost-effective and safe especially in scenarios where drug dose-related side effects are a concern. In this study, MRs are used to deliver anticancer drugs (doxorubicin) to cancer cells and subsequent cell death is evaluated in different cell lines (liver, prostate, and ovarian cancer cells). Cytocompatibility studies show that MRs are well-tolerated and internalized by cancer cells. Doxorubicin (DOX) is chemically conjugated with MRs (DOX-MRs) and magnetically steered toward cancer cells using the magnetic controller. Time-lapsed video shows that cells shrink and eventually die when MRs are internalized by cells. Taken together, this study confirms that microrobots are promising couriers for targeted delivery of therapeutic biomolecules for cancer therapy and other non-invasive procedures that require precise control.

Indexed as

Antineoplastic AgentsDoxorubicinCell DeathCell LineDrug Delivery SystemsHumansMaleAntineoplastic AgentsDoxorubicincancer therapydoxorubicindrug deliverylivermicrorobotsovaryprostate

Identifiers

PMID37378647
PMCPMC10753031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.